Health product recall

MAR-Cetirizine: Impurity

Last updated

Summary

Product
MAR-Cetirizine
Issue
Health products » Product quality
What to do

See instructions below.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

MAR-Cetirizine

MAR-Cetirizine 10mg

DIN 02427133

Tablet

Cetirizine Hydrochloride 10 mg

MC19002, MC19003

MAR-Cetirizine

MAR-Cetirizine 20mg

DIN 02427141

Tablet

Cetirizine Hydrochloride 20 mg

MC-20004, MC-20005A

Issue

The impurities are out of specification in the affected lots. 

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of Recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health product » Drugs
Companies

Marcan Pharmaceuticals Inc.

2 Gurdwara Road, Suite #112,

Ottawa, Ontario,

K2E 1A2

Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63566